Hiv Incidence(HIV 발병률)란 무엇입니까?
Hiv Incidence HIV 발병률 - We searched the PubMed, Embase, and Web of Science databases to identify relevant quantitative and qualitative studies on HIV incidence, HIV prevalence, HIV-related risk factors, HIV testing, antiretroviral therapy coverage and adherence, and interventions to improve treatment outcomes and reduce HIV risk factors. [1] , condom use, number of partners), HIV incidence, and ART/PrEP adherence and intervention cost-effectiveness. [2] Key populations are predicted to contribute more substantially to HIV incidence and morbidity in sub-Saharan Africa in the coming years. [3] There was limited geographic distribution of the studies, with a paucity of research in several counties and states where HIV incidence/prevalence is a concern. [4] Background The ECHO trial randomised 7829 women to depot medroxyprogesterone acetate (DMPA-IM), the copper intrauterine device (IUD) and the levonorgestrel (LNG) implant (1:1:1) and found no clear difference in HIV incidence between these three groups. [5] The indicator for reporting the progress of new infections is the HIV incidence. [6] 11 Despite huge improvements in access to antiretroviral therapy (ART) and an overall decline in HIV incidence in South Africa (SA), young women (15 24 years) remain uniquely vulnerable to infection. [7] Two assays available for cross-sectional incidence estimation, the BED capture immunoassay, and the Limiting Antigen (LAg) Avidity assay, measure a general characteristic of antibody response; performance of these assays can be affected and biased by factors such as viral suppression, resulting in sample misclassification and overestimation of HIV incidence. [8] Declines in HIV incidence have been slower than expected during the roll-out of antiretroviral treatment (ART) services in sub-Saharan African populations suffering generalized epidemics. [9] We assessed adherence to quarterly HIV prevention services and its impact on HIV incidence in MSM followed up in four cities in Burkina Faso, Côte d’Ivoire, Mali, and Togo. [10] Methods BCPP was designed to evaluate the impact of prevention interventions on HIV incidence in 30 communities in Botswana. [11] Further analyses to investigate mechanisms addressed associations with HIV incidence, rates of sexually transmitted infections, and substance use. [12] Univariate sensitivity analysis demonstrated that PrEP efficacy and HIV incidence had the greatest impact on cost-effectiveness. [13] Within Miami-Dade County, Black women experience disproportionate rates of HIV incidence and prevalence. [14] The integrated HIV-interventions, launched in early 2012, managed to reduce directly the HIV incidence and indirectly the HCV incidence. [15] This study aimed to investigate the trend in HIV incidence and its associated risk factors among MSM in Chengdu, China. [16] This study, a secondary analysis of the HPTN 068 randomized control trial, aimed to quantify the association of father and male presence with HIV incidence and first pregnancy among 2533 school-going adolescent girls and young women (AGYW) in rural South Africa participating in the trial between March 2011 and April 2017. [17] This study examined the spatial heterogeneity association of HIV incidence and socio-economic factors including poverty severity index,permanently employed females and males, unemployed females, percentage of poor households i. [18] When considering the overall group of 122 persons who came in to start PrEP, providing 114 PersonYears of followup, HIV incidence was 5. [19] A significant increase in HIV incidence was also observed for 1990 to 2005 (APC: 13. [20] We used an empiric risk score to assess HIV risk behaviors; HIV risk scores of ≥5 (corresponding to 5–15% HIV incidence) defined “high” HIV risk. [21] It is likely that as HIV incidence has decreased among heterosexuals from 1992-2013, mortality due to all causes has remained disparately high among racial/ethnic minorities, thereby outpacing new HIV cases. [22] ) South are disproportionately affected by HIV and experience significant disparities in HIV incidence, access to HIV care, and prevention across ages and socio-economic statuses. [23] A dynamic HIV model was used to estimate the population-attributable fraction (PAF; proportion of HIV infections prevented over 10 years when that risk factor is removed) of these risk factors to HIV transmission and impact on HIV incidence of reducing their prevalence. [24] Women, people aged 20 years and older, and residents from Vologda demonstrated the highest awareness of the main issues of HIV incidence (the nature of the disease, its impact on the body, ways and means of transmission). [25] We report time trends in and factors associated with HIV incidence between 2013 and 2019 among a cohort of GBMSM: the AURAH2 prospective study. [26] HIV incidence was 0. [27] Men who have sex with men (MSM) continue to constitute the majority of HIV incidence in Taiwan. [28] Limitations of our study are that these values are based on modelled estimates of HIV incidence and self-reported behavioural risk factors from national surveys. [29] ABSTRACT Black women experience disparities in HIV incidence. [30] HIV incidence was 0. [31] In Russia, COVID-19 will not contribute to an increase in HIV incidence and mortality in the near future. [32] Conclusions: MMC has already had a modest impact on HIV incidence in South Africa and can substantially impact South Africa’s HIV epidemic in the coming years. [33] Mathematical models are powerful tools in HIV epidemiology, producing quantitative projections of key indicators such as HIV incidence and prevalence. [34] We review the literature for evidence of reductions in HIV incidence, evaluate the extent to which decreases in HIV incidence can be reasonably attributed to VMMC programs, and summarize social harms and ethical concerns associated with these programs. [35] During the first decade of the AIDS pandemic (1981–1990), social and behavioral scientists contributed by designing theory-based and practical interventions, combining interventions into programs, and measuring impact on behavior change and HIV incidence. [36]우리는 PubMed, Embase 및 Web of Science 데이터베이스를 검색하여 HIV 발병률, HIV 유병률, HIV 관련 위험 요인, HIV 검사, 항레트로바이러스 치료 적용 범위 및 순응도, 치료 결과를 개선하고 HIV를 줄이기 위한 중재에 대한 관련 양적 및 질적 연구를 확인했습니다. 위험 요소. [1] , 콘돔 사용, 파트너 수), HIV 발병률, ART/PrEP 준수 및 중재 비용 효율성. [2] 주요 인구는 향후 몇 년 동안 사하라 사막 이남 아프리카에서 HIV 발병률과 이환율에 더 크게 기여할 것으로 예상됩니다. [3] 연구의 지리적 분포가 제한적이었고 HIV 발병률/유병률이 우려되는 여러 카운티 및 주에서 연구가 부족했습니다. [4] 배경 ECHO 시험은 무작위로 7,829명의 여성을 메드록시프로게스테론 아세테이트(DMPA-IM), 구리 자궁 내 장치(IUD) 및 레보놀게스트렐(LNG) 임플란트(1:1:1)를 저장하도록 했으며 이 세 그룹 간에 HIV 발병률에 명확한 차이가 없음을 발견했습니다. . [5] 새로운 감염의 진행 상황을 보고하는 지표는 HIV 발병률입니다. [6] 11 항레트로바이러스 요법(ART)에 대한 접근성이 크게 향상되고 남아프리카 공화국(SA)에서 HIV 발병률이 전반적으로 감소했음에도 불구하고 젊은 여성(15-24세)은 여전히 감염에 취약합니다. [7] 단면 발생률 추정에 사용할 수 있는 두 가지 분석, BED 포획 면역분석 및 제한 항원(LAg) 결합력 분석은 항체 반응의 일반적인 특성을 측정합니다. 이러한 분석의 성능은 바이러스 억제와 같은 요인에 의해 영향을 받고 편향될 수 있으며, 그 결과 샘플이 잘못 분류되고 HIV 발병률이 과대평가될 수 있습니다. [8] HIV 발병률 감소는 일반화된 전염병으로 고통받는 사하라 사막 이남의 아프리카 인구에서 항레트로바이러스 치료(ART) 서비스를 출시하는 동안 예상보다 느렸습니다. [9] 우리는 부르키나파소, 코트디부아르, 말리, 토고의 4개 도시에서 추적 관찰한 MSM에서 분기별 HIV 예방 서비스 준수와 HIV 발병에 미치는 영향을 평가했습니다. [10] 방법 BCPP는 보츠와나의 30개 지역사회에서 HIV 발병률에 대한 예방 개입의 영향을 평가하기 위해 고안되었습니다. [11] 메커니즘을 조사하기 위한 추가 분석은 HIV 발병률, 성병 감염률 및 약물 사용과의 연관성을 다루었습니다. [12] 단변량 민감도 분석은 PrEP 효능과 HIV 발병률이 비용 효율성에 가장 큰 영향을 미치는 것으로 나타났습니다. [13] Miami-Dade 카운티 내에서 흑인 여성은 불균형한 HIV 발병률과 유병률을 경험합니다. [14] 2012년 초에 시작된 통합 HIV 중재는 HIV 발병률을 직접적으로 줄이고 HCV 발병률을 간접적으로 줄이는 데 성공했습니다. [15] 이 연구는 중국 청두의 MSM에서 HIV 발병률의 추세와 관련 위험 요인을 조사하는 것을 목표로 했습니다. [16] HPTN 068 무작위 대조 시험의 이차 분석인 이 연구는 남아프리카 공화국 농촌 지역에서 2533명의 학교에 다니는 청소년 소녀와 젊은 여성(AGYW)을 대상으로 HIV 발병률 및 첫 임신과 아버지와 남성의 관계를 정량화하는 것을 목표로 했습니다. 2011년 3월부터 2017년 4월까지의 재판. [17] 본 연구에서는 HIV 발병률과 빈곤 심각도 지수, 정규직 여성 및 남성, 실업 여성, 빈곤 가구 비율 등 사회경제적 요인과의 공간적 이질성 연관성을 조사하였다. i. [18] 114 PersonYears의 추적 조사를 제공하는 PrEP를 시작하기 위해 온 122명의 전체 그룹을 고려할 때 HIV 발병률은 5였습니다. [19] 1990년에서 2005년 사이에 HIV 발병률이 크게 증가한 것으로 나타났습니다(APC: 13. [20] 우리는 HIV 위험 행동을 평가하기 위해 경험적 위험 점수를 사용했습니다. HIV 위험 점수가 5점 이상(HIV 발병률 5-15%에 해당)이면 "높은" HIV 위험이 정의됩니다. [21] 1992년부터 2013년까지 이성애자들 사이에서 HIV 발병률이 감소함에 따라 모든 원인으로 인한 사망률은 소수 인종/민족 사이에서 이례적으로 높게 유지되어 새로운 HIV 감염 사례를 앞질렀을 가능성이 있습니다. [22] ) 남부는 HIV에 의해 불균형적으로 영향을 받고 HIV 발병률, HIV 치료에 대한 접근성 및 예방에 있어 상당한 격차를 경험하고 있습니다. [23] 동적 HIV 모델을 사용하여 HIV 전파에 대한 이러한 위험 요인의 인구 기여 비율(PAF, 10년 동안 예방된 HIV 감염 비율) 및 유병률 감소가 HIV 발병률에 미치는 영향을 추정했습니다. [24] 여성, 20세 이상, 볼로그다 거주자는 HIV 발병의 주요 문제(질병의 특성, 신체에 미치는 영향, 전염 방식 및 수단)에 대해 가장 높은 인식을 보였습니다. [25] 우리는 GBMSM의 코호트인 AURAH2 전향적 연구에서 2013년과 2019년 사이에 HIV 발병률과 관련된 시간 경향 및 요인을 보고합니다. [26] HIV 발병률은 0이었습니다. [27] 남성과 성관계를 갖는 남성(MSM)은 계속해서 대만에서 HIV 발병률의 대부분을 차지합니다. [28] 우리 연구의 한계는 이러한 값이 국가 조사에서 자체 보고한 행동 위험 요인 및 HIV 발병률의 모형 추정치를 기반으로 한다는 것입니다. [29] 요약 흑인 여성은 HIV 발병률에서 격차를 경험합니다. [30] HIV 발병률은 0이었습니다. [31] 러시아에서 COVID-19는 가까운 장래에 HIV 발병률과 사망률의 증가에 기여하지 않을 것입니다. [32] 결론: MMC는 이미 남아프리카 공화국의 HIV 발병률에 약간의 영향을 미쳤으며 향후 몇 년 동안 남아프리카 공화국의 HIV 전염병에 상당한 영향을 미칠 수 있습니다. [33] 수학적 모델은 HIV 발병률 및 유병률과 같은 주요 지표의 정량적 예측을 생성하는 HIV 역학의 강력한 도구입니다. [34] 우리는 HIV 발병률 감소의 증거에 대한 문헌을 검토하고, HIV 발병률 감소가 VMMC 프로그램에 합리적으로 기인할 수 있는 정도를 평가하고, 이러한 프로그램과 관련된 사회적 피해 및 윤리적 문제를 요약합니다. [35] AIDS 전염병의 첫 10년(1981-1990) 동안 사회 및 행동 과학자들은 이론 기반 및 실제 개입을 설계하고 개입을 프로그램에 결합하고 행동 변화와 HIV 발병률에 대한 영향을 측정하는 데 기여했습니다. [36]
oral pre exposure 구두 사전 노출
Daily oral pre-exposure prophylaxis (PrEP) is a key tool in addressing high HIV incidence among young women, and breaking the cycle of transmission. [1] Summary Background As oral pre-exposure prophylaxis (PrEP) becomes the standard of prevention globally, its potential effect on HIV incidence in clinical trials of new prevention interventions is unknown, particularly for trials among women. [2] BACKGROUND Oral pre-exposure prophylaxis (PrEP) is highly effective for HIV prevention, but data are limited on HIV incidence among PrEP users in generalized epidemic settings, particularly outside of selected risk groups. [3] PURPOSE Young people of color have high HIV incidence rates and suffer the greatest health inequities with regard to daily oral pre-exposure prophylaxis. [4]매일 경구 노출 전 예방(PrEP)은 젊은 여성의 높은 HIV 발병률을 해결하고 전염의 순환 고리를 끊는 핵심 도구입니다. [1] 요약 배경 경구 노출 전 예방(PrEP)이 전 세계적으로 예방의 표준이 됨에 따라, 특히 여성을 대상으로 한 시험의 경우 새로운 예방 중재에 대한 임상 시험에서 HIV 발병에 대한 잠재적 영향은 알려져 있지 않습니다. [2] nan [3] nan [4]
Reduce Hiv Incidence HIV 발병률 감소
Given the important role of the vaginal microbiome in determining HIV susceptibility, altering the microbiome towards a Lactobacillus-dominated state is an attractive complementary strategy to reduce HIV incidence rates. [1] BACKGROUND HIV pre-exposure prophylaxis (PrEP) requires continued use at an effective dosage to reduce HIV incidence. [2] In addition to preventing HPV-associated cancers, increasing HPV vaccination coverage could potentially reduce HIV incidence. [3] ABSTRACT Background: The South African development goals for young women aged 15 to 24 are to reduce HIV incidence, teenage pregnancy and gender-based violence, and to increase school completion and economic security. [4] Poverty alleviation programs can reduce HIV incidence but may have greater impacts when combined with other psychosocial interventions. [5] While pre-exposure prophlaxis (PrEP) is a promising primary intervention strategy to reduce HIV incidence, the uptake of this biomedical prevention strategy has been very low. [6] Pre-exposure prophylaxis (PrEP) is a promising strategy to reduce HIV incidence among men who have sex with men (MSM). [7] Although pre-exposure prophylaxis (PrEP) can be expected to reduce HIV incidence, its uptake, adherence, and persistence remain limited, particularly among highest priority groups such as men who have sex with men and transwomen (MSMTW). [8] This highlights the success of biomedical HIV prevention strategies to reduce HIV incidence while affirming the need for new approaches to STI prevention. [9] BACKGROUND Improving HIV diagnosis, access to care and effective antiretroviral treatment provides our global strategy to reduce HIV incidence. [10] Combination prevention including UTT is cost-effective at thresholds greater than $800 per DALY averted and can be an efficient strategy to reduce HIV incidence in high-prevalence settings. [11] Introduction: Innovative HIV technologies can help to reduce HIV incidence, yet uptake of such tools is relatively low among young people. [12] BACKGROUND Through a multisectoral approach, the DREAMS Partnership aimed to reduce HIV incidence among adolescent girls and young women (AGYW) by 40% over 2 years in high-burden districts across sub-Saharan Africa. [13] Going forward, Full HR and ART could reduce HIV incidence by 58. [14] Background DREAMS promotes a comprehensive HIV prevention approach to reduce HIV incidence among adolescent girls and young women (AGYW). [15] Recent findings The SEARCH Universal test and treat (UTT) trial conducted in Kenya and Uganda aimed to reduce HIV incidence and improve community health. [16] BACKGROUND HIV pre-exposure prophylaxis (PrEP) has great potential to reduce HIV incidence among young black men who have sex with men (YBMSM) but initiation and persistence for this group remain low. [17]HIV 감수성을 결정하는 질내 미생물군집의 중요한 역할을 감안할 때, 미생물군집을 락토바실러스 우세 상태로 변경하는 것은 HIV 발병률을 줄이기 위한 매력적인 보완 전략입니다. [1] 배경 HIV 노출 전 예방(PrEP)은 HIV 발병률을 줄이기 위해 효과적인 용량으로 계속 사용해야 합니다. [2] nan [3] nan [4] nan [5] nan [6] nan [7] nan [8] nan [9] nan [10] nan [11] nan [12] nan [13] nan [14] nan [15] nan [16] nan [17]
High Hiv Incidence 높은 HIV 발병률
Guided by an implementation science research framework, we investigated the implementation of a PrEP initiative for WOC in a US city with high HIV incidence. [1] Key populations (KP) continue to account for high HIV incidence globally. [2] BACKGROUND Men who have sex with men (MSM) have high HIV incidence and prevalence burdens but relatively low HIV testing rates. [3] BACKGROUND The lack of acute and early HIV infection (AEHI) diagnosis and care contributes to high HIV incidence in resource-limited settings. [4] Given high HIV incidences in TGW these findings hold promise for TGW PrEP programming in the region. [5] Daily oral pre-exposure prophylaxis (PrEP) is a key tool in addressing high HIV incidence among young women, and breaking the cycle of transmission. [6] The uptake of HIV testing and linkage to care remains low among men, contributing to high HIV incidence in women in South Africa. [7] These misperceptions may lead to fatalism and reduced motivation for prevention efforts, possibly explaining the continued high HIV incidence in this community. [8] Integration of HIV and family planning (FP) services is a renewed focus area for national policymakers, donors, and implementers in sub-Saharan Africa as a result of high HIV incidence among general-population women, especially adolescent girls and young women (AGYW), and the perception that integrating HIV pre-exposure prophylaxis (PrEP) into FP services may be an effective way to provide comprehensive HIV and FP services to this population. [9] These services include those of family planning (FP) providers in high HIV incidence settings. [10] Several conditions have been attributed to the high HIV incidence and prevalence within this group, including experiences of discrimination, unemployment, incarceration, stigma, and elevated rates of sexual risk and substance use. [11] Adolescent girls and young women (AGYW) in Africa have high HIV incidence despite scale‐up of HIV testing and HIV treatment. [12] PURPOSE Young people of color have high HIV incidence rates and suffer the greatest health inequities with regard to daily oral pre-exposure prophylaxis. [13] The South also includes large populations residing in nonmetropolitan areas characterized by disproportionately high HIV incidence and diagnosis rates compared to Disclaimer The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. [14] High HIV incidence and low adherence to daily oral PrEP among women underscore the need for more acceptable and easier to use HIV prevention products. [15]구현 과학 연구 프레임워크에 따라 우리는 HIV 발병률이 높은 미국 도시에서 WOC에 대한 PrEP 이니셔티브의 구현을 조사했습니다. [1] 핵심 인구(KP)는 전 세계적으로 높은 HIV 발병률을 계속 설명합니다. [2] nan [3] nan [4] nan [5] 매일 경구 노출 전 예방(PrEP)은 젊은 여성의 높은 HIV 발병률을 해결하고 전염의 순환 고리를 끊는 핵심 도구입니다. [6] nan [7] nan [8] nan [9] nan [10] nan [11] nan [12] nan [13] nan [14] nan [15]
Reducing Hiv Incidence HIV 발병률 감소
The monthly dapivirine vaginal ring has proven efficacious in reducing HIV incidence in two Phase 3 clinical trials. [1] ABSTRACT Background: Pre-exposure prophylaxis (PrEP) for HIV prevention is safe and effective in reducing HIV incidence. [2] Methods We used survey data collected from 1,081 AGYW aged 15–22 years from two Nairobi’s informal settlements of Korogocho (n = 617) and Viwandani (n = 464) in 2017 through DREAMS (an initiative aimed at reducing HIV incidence among AGYW with a core package of evidence-based interventions) impact evaluation project. [3] BACKGROUND Reducing HIV incidence requires addressing persistent racial/ethnic disparities in HIV burden. [4] 4-6 Effectively reducing HIV incidence among MSM necessitates access to inclusive and queer-competent health care. [5] Understanding the determinants of pre-exposure prophylaxis (PrEP) adherence is integral to reducing HIV incidence in the United States, especially for those at highest risk. [6] Adolescent and young adult MSM are particularly vulnerable and reducing HIV incidence among this priority population will require substantial levels of uptake of multiple prevention strategies (i. [7] Increasing knowledge of status and treatment coverage among older men could be crucial to reducing HIV incidence among women in sub-Saharan Africa, and by extension, reducing mother-to-child transmission. [8] Given the importance of voluntary medical male circumcision (VMMC) in reducing HIV incidence, access to and use of quality data for programme planning and management are essential. [9] To effectively maximize presentation for care and subsequently amplify uptake of PrEP, growing the base of providers who offer PrEP to eligible patients can provide a meaningful public health impact on reducing HIV incidence. [10] While these interventions have had a fundamental impact in reducing HIV incidence, the burden in many populations remains. [11] However, four large cluster-randomized population-level trials on universal HIV testing and treatment in Africa have not delivered the expected impact in reducing HIV incidence at a population level. [12]월간 dapivirine 질 링은 2건의 3상 임상 시험에서 HIV 발병률 감소에 효과적인 것으로 입증되었습니다. [1] 초록 배경: HIV 예방을 위한 사전 노출 예방(PrEP)은 HIV 발병률을 줄이는 데 안전하고 효과적입니다. [2] nan [3] nan [4] nan [5] nan [6] nan [7] nan [8] nan [9] nan [10] nan [11] nan [12]
Highest Hiv Incidence 가장 높은 HIV 발병률
, Black men are disproportionately affected by HIV, with some of the highest HIV incidence rates and lowest rates of HIV testing. [1] Objectives Portugal has the highest HIV incidence rate in Western Europe. [2] org, in the 20 metropolitan areas with the highest HIV incidence. [3] The highest HIV incidence in 2019 was registered in Krasnoyarsk region (94,6), and the highest TB incidence in ChAD (136,1). [4] In South Africa adolescent girls have the highest HIV incidence of any sex or age cohort. [5] We find there is little trade-off between effectiveness and equality of outcome when choosing groups to target for PrEP in LAC – by focusing on MSM with the highest HIV incidence (Black), we can reduce both overall infections and racial/ethnic disparities. [6] Targeting age cohorts with the highest HIV incidence (18-year-old women and 23-year-old men) would increase the impact to up to 697 000 new infections prevented, given full booster retention. [7], 흑인 남성은 HIV 감염률이 가장 높으며 HIV 검사 비율이 가장 낮은 HIV에 불균형적으로 영향을 받습니다. [1] 목표 포르투갈은 서유럽에서 HIV 발병률이 가장 높습니다. [2] nan [3] nan [4] nan [5] nan [6] nan [7]
Background Hiv Incidence 배경 HIV 발병률
We used the well‐characterized adherence‐efficacy relationship for F/TDF to back‐calculate the (non‐PrEP) counterfactual background HIV incidence (bHIV) in a randomized trial of a novel PrEP agent and estimate comparative efficacy (to counterfactual bHIV). [1] Background HIV incidence can be estimated with cross-sectional studies using clinical, serological, and molecular data. [2] Background HIV incidence among South African adolescent girls and young women (AGYW) remains high, but could be reduced by highly effective pre-exposure prophylaxis (PrEP). [3] Background HIV incidence is growing most rapidly in the United States among young men who have sex with men (YMSM). [4]우리는 F/TDF에 대한 잘 규명된 순응도-효능감 관계를 사용하여 새로운 PrEP 제제의 무작위 시험에서 (비 PrEP) 반사실적 배경 HIV 발병률(bHIV)을 역계산하고 비교 효능(반사실적 bHIV에 대한)을 추정했습니다.